The effect of treatment duration on the prognosis of adhd: a multi-center naturalistic follow-up study

Basit Öğe Kaydı
dc.contributor.authorErcan, Eyuep Sabri
dc.contributor.authorBilgic, Ayhan
dc.contributor.authorTufan, Ali Evren
dc.contributor.authorAkca, Omer Faruk
dc.contributor.authorYazici, Ipek Percinel
dc.contributor.authorBilac, Oznur
dc.contributor.authorTahillioglu, Akin
dc.date.accessioned2025-07-23T20:44:15Z
dc.date.available2025-07-23T20:44:15Z
dc.date.issued2025
dc.departmentİstanbul Esenyurt Üniversitesi
dc.description.abstractObjective: This study aimed to evaluate the effect of medication duration over a 5-year period on the prognosis of Attention-Deficit/ Hyperactivity Disorder (ADHD) and the accompanying disruptive behavioral symptoms using a naturalistic methodology. Methods: The sample comprised 576 ADHD cases referred to 16 Child and Adolescent Psychiatry Clinics in 13 cities in T & uuml;rkiye, aged between 7-12 five years ago and 12-18 currently. Baseline and current Turgay DSM-IV Disruptive Behavior Disorders Rating Scale (T-DSM-IV-S) scores completed by parents were compared. Sociodemographic data, treatment processes, life events, and habits were recorded. Disorder severity and recovery levels were determined using the Clinical Global Impression Scale (CGI). Results: All current T-DSM-IV-S scores were significantly lower than the baseline scores. Longer duration of medication use, receiving psychotherapy, and higher socioeconomic status were associated with better CGI scores in the present study. However, increased baseline conduct disorder symptoms, being bullied, longer duration of Internet usage, dropping out of school, smoking, and older age were associated with worse CGI scores. Conclusion: Our study indicates that a longer duration of medication use is associated with better global improvement in children with ADHD. Better identification of the factors that may directly or indirectly affect the general improvement in ADHD cases and changing these factors may enable a more positive prognosis.
dc.identifier.doi10.1016/j.psychres.2025.116588
dc.identifier.issn0165-1781
dc.identifier.issn1872-7123
dc.identifier.pmid40526991
dc.identifier.scopus2-s2.0-105008130798
dc.identifier.scopusqualityN/A
dc.identifier.urihttps://doi.org/10.1016/j.psychres.2025.116588
dc.identifier.urihttps://hdl.handle.net/20.500.14704/1125
dc.identifier.volume351
dc.identifier.wosWOS:001513878400001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofPSYCHIATRY RESEARCH
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250711
dc.subjectADHD
dc.subjectMedication
dc.subjectTreatment duration
dc.subjectPrognosis
dc.subjectClinical outcomes
dc.titleThe effect of treatment duration on the prognosis of adhd: a multi-center naturalistic follow-up study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu